Patents by Inventor Yong Huh

Yong Huh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11954890
    Abstract: The present disclosure relates to an apparatus and method for fast refining segmentation for a V-PCC encoder. The apparatus may include a grid segmentation unit segmenting a coordinate space of a point cloud into grid units, and an edge cube search unit searching a cube containing one or more points among the cubes segmented into grid units and containing a segment boundary. The apparatus may also include a surrounding cube search unit searching an edge surrounding cube containing one or more points within a predetermined range from the edge cube, and a smooth score calculation unit calculating smooth scores for all the edge surrounding cubes and all the edge cubes. The apparatus may further include a projection plane index update unit obtaining a normal score based on the calculated smooth scores and updating a projection plane index of each point in the edge cube using the normal score.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: April 9, 2024
    Assignee: Korea Electronics Technology Institute
    Inventors: Yong Hwan Kim, Jieon Kim, JinGang Huh, Jong-geun Park
  • Publication number: 20240091320
    Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid sequence with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has an outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Application
    Filed: August 9, 2023
    Publication date: March 21, 2024
    Inventors: Sang Jae KIM, Kyung Hee KIM, Kyu-Yong LEE, Seong-Ho KOH, Hyun-Hee PARK, Sung Jin HUH, Woo Jin LEE, Bum Joon KIM
  • Patent number: 11918781
    Abstract: An infusion flow regulator includes: a main body having an inlet through which fluid is introduced and an outlet through which the fluid is discharged; and a rotary dial rotatably coupled to the main body, with a sealing member interposed therebetween, so as to regulate a flow rate of the fluid, in which the rotary dial includes a regulating flow path having a shape of a recessed groove in cross section with a first width and a first height, and the regulating flow path includes a first region in which the first width is constant and the first height is decreased, and a second region in which both the first width and the first height are decreased. By the aforementioned configuration, the infusion flow regulator for the fluid can accurately regulate the flow rate even in a region where the flow rate of the fluid is very small.
    Type: Grant
    Filed: May 27, 2019
    Date of Patent: March 5, 2024
    Assignee: Korea Aerospace Research Institute
    Inventors: Poo Min Park, Hyung Mo Kim, Tae Choon Park, Young Seok Kang, Jae Sung Huh, Doo Yong Lee
  • Publication number: 20090137776
    Abstract: The present invention relates to a process for producing tetrahydrofuran polymer or tetrahydrofuran copolymer by using heteropolyacid catalyst, and more particularly, to a process for producing tetrahydrofuran polymer by using hydronium ion water having a pH of 5.5 or less as a reaction initiator in the initiation step.
    Type: Application
    Filed: October 22, 2008
    Publication date: May 28, 2009
    Applicant: HYOSUNG CORPORATION
    Inventors: Eun-Ku Lee, Yong-Ho Baek, Joon-Seok Oh, No-Hyun Kim, Jae-Yong Huh
  • Publication number: 20070063926
    Abstract: A plasma display apparatus and a method of driving the plasma display apparatus are provided. The plasma display apparatus includes a plasma display panel including a first electrode and a second electrode, a first electrode driver, and a second electrode driver. The first electrode driver supplies a first falling signal of a voltage magnitude, that is more than a voltage magnitude of a scan signal supplied during an address period, to the first electrode before the supply of a rising signal with a gradually rising voltage in at least one subfield of several subfields of a frame. The second electrode driver supplies a second signal having a polarity opposite a polarity of the first falling signal to the second electrode during the supply of the first falling signal.
    Type: Application
    Filed: May 23, 2006
    Publication date: March 22, 2007
    Inventors: Yun Jung, Muk Kim, Byung Kim, Yong Huh
  • Patent number: 6071734
    Abstract: The present invention relates to hepatitis B virus (hereinafter it refers to HBV) polymerase containing a histidine tag, RNase H enzyme derived from HBV polymerase and processes for preparation thereof. More particularly, the present invention relates to recombinant HBV polymerase, its RNase H domain with enzyme activity, expression vectors producing the enzymes in E. coli and processes for preparing the HBV polymerase and the RNase H enzyme which can be easily purified due to their histidine tags. And the present invention relates to uses of the HBV polymerase and the RNase H enzyme for screening antiviral agents.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: June 6, 2000
    Assignee: Dong Wha Pharm. Ind. Co., Ltd.
    Inventors: Sung-June Yoon, Jong-Woo Kim, Yong Huh, Hyune-Mo Rho, Gu-Hung Jung
  • Patent number: 5968781
    Abstract: The present invention relates to hepatitis B virus (hereinafter it refers to HBV) polymerase containing a histidine tag, RNase H enzyme derived from HBV polymerase and processes for preparation thereof.More particularly, the present invention relates to recombinant HBV polymerase, its RNase H domain with enzyme activity, expression vectors producing the enzymes in E. coli and processes for preparing the HBV polymerase and the RNase H enzyme which can be easily purified due to their histidine tags.And the present invention relates to uses of the HBV polymerase and the RNase H enzyme for screening antiviral agents.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: October 19, 1999
    Assignee: Dong Wha Pharm. Ind. Co., Ltd.
    Inventors: Sung-June Yoon, Jong-Woo Kim, Yong Huh, Hyune-Mo Rho, Gu-Hung Jung
  • Patent number: 5922871
    Abstract: The present invention relates to novel terephthalamide derivatives and in particular to novel terephthalamide derivatives of the following formula 1, its pharmaceutically acceptable salts as antiviral agents having remarkable inhibitory actions against the proliferation of various viruses including HIV and HBV, and preparing method thereof ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are the same as defined in the detailed description of the present invention.
    Type: Grant
    Filed: October 23, 1997
    Date of Patent: July 13, 1999
    Assignee: Dongwha Pharmaceutical Ind. Co., Ltd.
    Inventors: Sung Joon Yoon, Yong Ho Chung, Sang Wook Lee, Hyeong Su Sim, Yong Kyun Park, Jong Woo Kim, Yong Huh, Jae In Yoon, Sang Jin Park